<p>A) Neutralisation and ADE of all four DENV serotypes, ZIKV, WNV and YFV, with DENV anti-3DI/DII and anti-4DI/DII pooled sera (in all cases, n = 3 for each virus-sera combination). B) FRNT<sub>50</sub> titres, as determined in (A), * indicates FRNT<sub>50</sub> titres below detection limit of the assay (≥25).</p
<p>(A) Flow cytometry data of both FcγRI and FcγRII (green histogram) in THP-1 and K562. Mock (red h...
<p>Blockade of binding assay where DENV2 natural infection immune sera (A, B) or DENV2 monovalent va...
<p>(A) Analysis of virus-specific antibody titers in anti-DENV-2 E antisera (blue bars) and mock-imm...
<p>Immunofluorescence of Vero cells infected with all four DENV serotypes and reacted with antibodie...
<p>Serially diluted pooled immune sera from vaccine constructs B16, B29, B38, B45, B64 and B19 were ...
<p>Neutralization titers of MixBiEDIII immune sera at two weeks after the last immunization were mea...
<p>The capability of the cross reactive antibodies to neutralize DENV1, DENV2, DENV3 or DENV4 was te...
<p>DENV2 immune sera (A) and monovalent vaccine sera (B) were evaluated for their ability to neutral...
<p><b>A.</b> DENV-specific neutralization of the serum at 3 months post-onset of symptoms in 2° DENV...
<p><b>A</b>) DENV-binding ELISA shows that depletion of a primary DENV3-immune serum (DT118) with DE...
A) DENV1-4 specific IgG titers were determined for week 3, 4, 10 and 16. B) The neutralizing activit...
<p><b>A</b>: Sera of 24 patients with DENV-1 infection. <b>B</b>: sera of 11 patients with DENV-2 in...
<p>Sixty serum samples exhibiting neutralizing activity to DENV were analyzed for presence of infect...
<p><b>(A)</b> Immunofluorescence of Vero cells infected with DENV of each serotype, reacted with the...
To determine the portion of serotype-specific neutralizing antibodies, sera from A) TR and B) TNR im...
<p>(A) Flow cytometry data of both FcγRI and FcγRII (green histogram) in THP-1 and K562. Mock (red h...
<p>Blockade of binding assay where DENV2 natural infection immune sera (A, B) or DENV2 monovalent va...
<p>(A) Analysis of virus-specific antibody titers in anti-DENV-2 E antisera (blue bars) and mock-imm...
<p>Immunofluorescence of Vero cells infected with all four DENV serotypes and reacted with antibodie...
<p>Serially diluted pooled immune sera from vaccine constructs B16, B29, B38, B45, B64 and B19 were ...
<p>Neutralization titers of MixBiEDIII immune sera at two weeks after the last immunization were mea...
<p>The capability of the cross reactive antibodies to neutralize DENV1, DENV2, DENV3 or DENV4 was te...
<p>DENV2 immune sera (A) and monovalent vaccine sera (B) were evaluated for their ability to neutral...
<p><b>A.</b> DENV-specific neutralization of the serum at 3 months post-onset of symptoms in 2° DENV...
<p><b>A</b>) DENV-binding ELISA shows that depletion of a primary DENV3-immune serum (DT118) with DE...
A) DENV1-4 specific IgG titers were determined for week 3, 4, 10 and 16. B) The neutralizing activit...
<p><b>A</b>: Sera of 24 patients with DENV-1 infection. <b>B</b>: sera of 11 patients with DENV-2 in...
<p>Sixty serum samples exhibiting neutralizing activity to DENV were analyzed for presence of infect...
<p><b>(A)</b> Immunofluorescence of Vero cells infected with DENV of each serotype, reacted with the...
To determine the portion of serotype-specific neutralizing antibodies, sera from A) TR and B) TNR im...
<p>(A) Flow cytometry data of both FcγRI and FcγRII (green histogram) in THP-1 and K562. Mock (red h...
<p>Blockade of binding assay where DENV2 natural infection immune sera (A, B) or DENV2 monovalent va...
<p>(A) Analysis of virus-specific antibody titers in anti-DENV-2 E antisera (blue bars) and mock-imm...